ES2186694T3 - Vacuna bacteriana para el tratamiento de necrosis hepatica causada por f. necrophorum. - Google Patents

Vacuna bacteriana para el tratamiento de necrosis hepatica causada por f. necrophorum.

Info

Publication number
ES2186694T3
ES2186694T3 ES95105058T ES95105058T ES2186694T3 ES 2186694 T3 ES2186694 T3 ES 2186694T3 ES 95105058 T ES95105058 T ES 95105058T ES 95105058 T ES95105058 T ES 95105058T ES 2186694 T3 ES2186694 T3 ES 2186694T3
Authority
ES
Spain
Prior art keywords
treatment
necrophorum
bacterial vaccine
necrosis caused
hepatic necrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95105058T
Other languages
English (en)
Inventor
John N Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Bayer Corp
Original Assignee
Bayer AG
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG, Bayer Corp filed Critical Bayer AG
Application granted granted Critical
Publication of ES2186694T3 publication Critical patent/ES2186694T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/114—Fusobacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

METODO PARA EL TRATAMIENTO DEL GANADO VACUNO Y LANAR PARA PREVENIR LA NECROSIS DEL HIGADO, QUE COMPRENDE LA ADMINISTRACION DE UNA BACTERINA DE FUSOBACTERIUM NECROPHORUM.
ES95105058T 1990-06-07 1991-05-25 Vacuna bacteriana para el tratamiento de necrosis hepatica causada por f. necrophorum. Expired - Lifetime ES2186694T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53489490A 1990-06-07 1990-06-07

Publications (1)

Publication Number Publication Date
ES2186694T3 true ES2186694T3 (es) 2003-05-16

Family

ID=24131961

Family Applications (2)

Application Number Title Priority Date Filing Date
ES91108517T Expired - Lifetime ES2084057T3 (es) 1990-06-07 1991-05-25 Bacterina para el tratamiento de enfermedades causadas por f. necrophorum y procedimiento para su produccion.
ES95105058T Expired - Lifetime ES2186694T3 (es) 1990-06-07 1991-05-25 Vacuna bacteriana para el tratamiento de necrosis hepatica causada por f. necrophorum.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES91108517T Expired - Lifetime ES2084057T3 (es) 1990-06-07 1991-05-25 Bacterina para el tratamiento de enfermedades causadas por f. necrophorum y procedimiento para su produccion.

Country Status (8)

Country Link
US (1) US6132709A (es)
EP (2) EP0460480B1 (es)
AU (1) AU644440B2 (es)
CA (1) CA2043932C (es)
DE (2) DE69133172T2 (es)
ES (2) ES2084057T3 (es)
IE (1) IE72181B1 (es)
NZ (1) NZ238378A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0648260B1 (en) * 1992-06-26 2000-09-27 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vaccine
US5455034A (en) * 1992-06-26 1995-10-03 Kansas State University Research Foundation Fusobacterium necrophorum leukotoxoid vaccine
US5861162A (en) * 1995-06-07 1999-01-19 Kansas State University Research Foundation Multivalent inocula for lessening incidence of liver abscesses in cattle
BR9610775A (pt) * 1995-06-07 1999-07-13 Univ Kansas State Vacinas de actinomyces pyogenes e de actinomyces pyogenes/fusobacterium necrophorum para imunizar gado e carneiros
US6632439B2 (en) 1999-09-29 2003-10-14 Novartis Animal Health, Inc. Fusobacterium necrophorum vaccine and method for making such vaccine
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin
NZ586669A (en) 2008-01-18 2012-06-29 Werner Lubitz Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation
CN102648003B (zh) 2009-10-09 2016-01-13 儿童医疗中心有限公司 选择性裂解的全细胞疫苗
WO2014084964A1 (en) 2012-11-29 2014-06-05 Cornell University Vaccine for intrauterine disease
WO2025160664A1 (en) * 2024-01-31 2025-08-07 University Of Saskatchewan Methods and uses of fusobacterium necrophorum immunogenic compositions and vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA984293A (en) * 1971-08-20 1976-02-24 Richard W. Moore Medium and method for growth of superiorly antigenic equine infectious anemia virus and production of immunizing vaccine therefrom
FR2174745A1 (en) * 1972-03-09 1973-10-19 Inst Elevage Med Vet Mixed veterinary vaccine - active against symptomatic and bacterial anthrax
US4061751A (en) * 1976-07-22 1977-12-06 American Cyanamid Company 6-Substituted 3-nitroimidazo[1,2-b]pyridazine for the control of foot rot and liver lesions in ruminant animals
US4203968A (en) * 1978-08-18 1980-05-20 Iowa State University Research Foundation, Inc. Combination vaccine for swine dysentery and method of use
ATE117899T1 (de) * 1987-09-28 1995-02-15 Beecham Inc Tgev-virus vom schwein als impfstoff für hunde.

Also Published As

Publication number Publication date
EP0460480A3 (en) 1992-04-01
DE69133172D1 (de) 2003-01-23
EP0460480B1 (en) 1996-01-24
CA2043932A1 (en) 1991-12-08
EP0460480A2 (en) 1991-12-11
DE69116606D1 (de) 1996-03-07
CA2043932C (en) 2006-09-12
ES2084057T3 (es) 1996-05-01
IE911940A1 (en) 1991-12-18
EP0674905A3 (en) 1995-12-06
EP0674905A2 (en) 1995-10-04
AU7817791A (en) 1991-12-12
DE69116606T2 (de) 1996-05-30
EP0674905B1 (en) 2002-12-11
AU644440B2 (en) 1993-12-09
US6132709A (en) 2000-10-17
IE72181B1 (en) 1997-03-26
DE69133172T2 (de) 2003-04-30
NZ238378A (en) 1992-12-23

Similar Documents

Publication Publication Date Title
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
ES2052495T3 (es) Terapia de fluidos con aniones l-lactato y/o piruvato.
CO5221085A1 (es) Mejoramiento de la condicion de mascotas anosas
MX9206851A (es) Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene.
ECSP941111A (es) Nuevas sulfonilaminopirimidinas,
DE3679908D1 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
ES2145774T3 (es) Derivados de adenosina que tienen actividad agonista en a2.
ES2114056T3 (es) Uso de derivados nor y homo de acidos biliares como potenciadores de absorcion para medicamentos.
ES2142432T3 (es) Forma de dosificacion de la gepirona.
CO5700796A2 (es) Composiciones que contienen piperacilina y tazobactam utiles para inyecciones
MX9201245A (es) Nueva formulacion de vacuna para tratar infecciones cuasadas por el virus de herpes simple.
ES2186694T3 (es) Vacuna bacteriana para el tratamiento de necrosis hepatica causada por f. necrophorum.
DE69114498D1 (de) Kurzbettige, einfach ungesättigte fettsäuren enthaltende nahrungsmittel und pharmazeutische zusammensetzungen sowie deren anwendungen.
ES2095421T3 (es) Composiciones termoconformables, su procedimiento de preparacion y su utilizacion para la obtencion de articulos termoconformados.
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
DK0589893T3 (da) Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
PT952974E (pt) Derivados bifenilicos substituidos por um radical aromatico ou heteroaromatico e composicoes farmaceuticas e cosmeticas que os contem
ES2069705T3 (es) Composicion de herbicida postemergente que contiene glicol de silicona y dispersante.
MX9201058A (es) Derivados ciclicos de cetal, procedimiento para supreparacion y composicion farmaceutica que los contiene.
ES2078507T3 (es) Medicinas y derivados de sulfonanilida.
ES2103733T3 (es) Procedimiento para combatir el piojo de los peces.
ES2095861T3 (es) Composiciones con antibioticos estabilizadas para la alimentacion animal.
ES2045348T3 (es) Metodo para preparar derivados de lactamimida para el tratamiento o la prevencion de paludismo farmaco-resistente.
ES2184987T3 (es) Formas de administracion solidas de liberacion instantanea y procedimiento para su preparacion.